Evidence map›Paper›PMID 27979990›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients.

Mara A McAdams-DeMarco, Sunjae Bae, Nadia Chu, Alden L Gross, Charles H Brown, Esther Oh, Paul Rosenberg, Karin J Neufeld, Ravi Varadhan, Marilyn Albert and 2 more

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Sleep disorders and sleep medications as risk factors for dementia in kidney transplant recipients: A retrospective cohort study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  6. ACS pharmacology & translational science · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Residential Racial and Ethnic Segregation and Post-Kidney Transplant Dementia, Allograft Loss, and Mortality.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Article
  14. Article
  15. Sleep duration and cognitive function among older adults with chronic kidney disease: results from the National Health and Nutrition Examination Survey (2011-2014).Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  16. Long-term cognitive impairments in kidney transplant recipients: impact on participation and quality of life.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  17. Review
  18. Delirium, changes in cognitive function, and risk of diagnosed dementia after kidney transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  19. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Mara A McAdams-DeMarcoDepartments of Surgery, mara@jhu.edu dorry@jhmi.edu.
Sunjae BaeDepartments of Surgery.
Nadia ChuDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland; and.
Alden L GrossDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland; and.
Charles H BrownAnesthesiology & Critical Care Medicine, and.
Esther OhMedicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Paul RosenbergMedicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Karin J NeufeldMedicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Ravi VaradhanDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
Marilyn AlbertMedicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Jeremy WalstonMedicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Dorry L SegevDepartments of Surgery, mara@jhu.edu dorry@jhmi.edu.
Johns Hopkins University · USJohns Hopkins Medicine · USSidney Kimmel Comprehensive Cancer Center · USSociety of Critical Care Medicine · US

Funding

Technological Assessment and Solutions Core - RC4P30AG021334 · NIA · JOHNS HOPKINS UNIVERSITY · PI Jeremy D Walston · 2003 to 2026
$33.2M
EPIDEMIOLOGY AND BIOSTATISTICS OF AGINGT32AG000247 · NIA · JOHNS HOPKINS UNIVERSITY · PI Karen J. Bandeen-Roche · 1996 to 2026
$13.2M
Frailty and Risk Prediction in Older Adults Considering Kidney Transplantation Supp OlorundareR01AG042504 · NIA · JOHNS HOPKINS UNIVERSITY · PI SEGEV, DORRY L. · 2013 to 2017
$3.4M
Patient Oriented Research in Kidney Disease and Transplant SurgeryK24DK101828 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SEGEV, DORRY L. · 2014 to 2018
$922k
Frailty and Adverse Health Outcomes of Aging in Older Adults with Kidney FailureK01AG043501 · NIA · JOHNS HOPKINS UNIVERSITY · PI MCADAMS DEMARCO, MARA A. · 2014 to 2018
$624k
NIA NIH HHS K01 AG043501NIA NIH HHS P30 AG021334NIA NIH HHS R01 AG042504NIDDK NIH HHS K24 DK101828
6 · The paper itself

Abstract

Older patients with ESRD who receive a kidney transplant (KT) may develop post-KT dementia and Alzheimer's disease (AD) associated with their long-standing kidney disease and/or neurotoxic immunosuppressant agents. To investigate this possibility, we studied 40,918 older (aged ≥55 years) KT recipients (January 1, 1999 to December 31, 2011) linked to Medicare claims through the US Renal Data System. We estimated dementia and AD risk (cumulative incidence) and studied factors associated with these sequelae using competing risks models. We estimated the risk of death-censored graft loss and mortality after developing dementia or the AD subtype of dementia, separately, using adjusted Cox proportional hazards models. Older recipients had a 10-year dementia risk ranging from 5.1% for recipients aged 55-60 years to 17.0% for recipients aged ≥75 years; 10-year AD risk ranged from 1.0% to 6.7%, respectively. The strongest predictors for dementia and AD were older recipient age and pretransplant diabetes. The 10-year graft loss risk was 28.8% for those who did not develop dementia and 43.1% for those who did, and the corresponding mortality risks were 55.7% and 89.9%, respectively. Older recipients with dementia had a 1.52-fold (95% confidence interval, 1.39 to 1.68) increased risk of graft loss and a 2.38-fold (95% confidence interval, 2.26 to 2.49) increased risk of mortality. We observed similar results for AD. We conclude that older KT recipients have a high risk of post-KT dementia and AD, and these sequelae associate with a profound effect on patient and graft survival.

Indexed as

Kidney TransplantationAgedAge FactorsAlzheimer DiseaseDementiaFemaleHumansKidney Failure, ChronicMaleMiddle AgedPostoperative ComplicationsRisk Assessmentdementiaepidemiology and outcomeskidney transplantation

Identifiers

PMID27979990
PMCPMC5407731
OpenAlexW2561657679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.